World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
53144
World Ranking
3613
National Ranking
1994

Hiroyuki Shimada publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hiroyuki Shimada sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,064 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hiroyuki Shimada D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hiroyuki Shimada sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hiroyuki Shimada is a researcher affiliated with Stanford University in the United States. Their work primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields including Neurology, Molecular Biology, Cancer Research, Genetics, and Physiology.

The main research topics studied by Shimada include:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Glioma Diagnosis and Treatment
  • Cancer therapeutics and mechanisms
  • Neurofibromatosis and Schwannoma Cases

Shimada's publication record features work in a variety of scientific journals. The frequent venues for publication include:

  • Journal of Clinical Oncology
  • Cancer Research
  • Pediatric Blood & Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Medicine

Selected recent papers authored or co-authored by Shimada include:

  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease, 2020, Nature Medicine
  • Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group, 2021, Journal of Clinical Oncology
  • Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma, 2021, Nature Communications
  • Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results, 2023, Nature Medicine
  • Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium, 2021, Journal of Clinical Oncology

Frequent collaborators include:

  • Bill Chiu
  • Julie R. Park
  • Naohiko Ikegaki
  • Arlene Naranjo
  • Susan L. Cohn

Best Publications

  • The International Neuroblastoma Pathology Classification (the Shimada system)

    Hiroyuki Shimada M.D.;Inge M. Ambros;Louis P. Dehner;Jun-ichi Hata

  • Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas

    Hiroyuki Shimada;Jane Chatten;William A. Newton;Nancy Sachs

  • Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Katherine K. Matthay;C. Patrick Reynolds;Robert C. Seeger;Hiroyuki Shimada

  • Terminology and morphologic criteria of neuroblastic tumors : recommendations by the International Neuroblastoma Pathology Committee

    Hiroyuki Shimada M.D.;Inge M. Ambros;Louis P. Dehner;Jun-ichi Hata

  • Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques

    Takaomi C Saido;Takeshi Iwatsubo;David M.A Mann;Hiroyuki Shimada

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Inhibition of Invasion and Metastasis in Cells Transfected with an Inhibitor of Metalloproteinases

    Yves A. DeClerck;Norma Perez;Hiroyuki Shimada;Thomas C. Boone

  • The comparative ability of eight functional mobility tests for predicting falls in community-dwelling older people

    Anne Tiedemann;Hiroyuki Shimada;Catherine Sherrington;Susan Murray

  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

    Nicolas R Barthélemy;Yan Li;Nelly Joseph-Mathurin;Brian A Gordon

  • A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia

    Takami Tomiyama;Tetsu Nagata;Hiroyuki Shimada;Rie Teraoka

  • Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

    Steven DuBois;Yan Kalika;John Lukens;Garrett Brodeur

  • A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment

    Takao Suzuki;Hiroyuki Shimada;Hyuma Makizako;Takehiko Doi

  • A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo

    Takami Tomiyama;Shogo Matsuyama;Hiroyuki Iso;Tomohiro Umeda;Tomohiro Umeda

  • Combined Prevalence of Frailty and Mild Cognitive Impairment in a Population of Elderly Japanese People

    Hiroyuki Shimada;Hyuma Makizako;Takehiko Doi;Daisuke Yoshida

  • Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy

    Kishore B. Challagundla;Petra M. Wise;Paolo Neviani;Haritha Chava

  • Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist.

    Tobey J. MacDonald;Takashi Taga;Hiroyuki Shimada;Peyman Tabrizi

  • International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

    Hiroyuki Shimada M.D.;Shunsuke Umehara;Yasumasa Monobe;Yoichi Hachitanda

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

  • Prevalence of frailty in Japan: A systematic review and meta-analysis.

    Gotaro Kojima;Steve Iliffe;Yu Taniguchi;Hiroyuki Shimada

  • Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation.

    W A Newton;E H Soule;A B Hamoudi;H M Reiman

Frequent Co-Authors

Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
Wendy B. London
Wendy B. London Harvard University
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Susan L. Cohn
Susan L. Cohn University of Chicago
Richard Sposto
Richard Sposto University of Southern California
Timothy J. Triche
Timothy J. Triche Van Andel Institute
Daniel O. Stram
Daniel O. Stram University of Southern California
Takao Takahashi
Takao Takahashi Keio University
Hidenori Arai
Hidenori Arai Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor. There are many related pathways and online degree options that offer flexibility and diverse job opportunities. For instance, those interested in the business side of healthcare can explore medical billing and coding online schools—a field with strong job demand and the option to study remotely, often with financial aid available.

Nursing remains one of the most rewarding and in-demand healthcare roles. If standardized entrance exams seem like a barrier, you can consider nursing schools that don't require teas or hesi, making entry into the field more accessible for many students.

Those drawn to leadership roles may opt for an online healthcare administration degree, offering accelerated programs designed to quickly prepare you for managing healthcare organizations. For practicing RNs, advancing your clinical skills and career prospects is possible through rn to np bridge programs, which provide a streamlined route to becoming a nurse practitioner.

Exploring these alternatives can open new doors in healthcare while accommodating different backgrounds and career goals.

Best Scientists Citing Hiroyuki Shimada

Trending Scientists

Recently Published Articles